Oncology
1 drug is in development for Oligodendroglioma.
- Companies
- 1
- Clinical trials
- 8
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Oligodendroglioma pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| safusidenib | Nuvation Bio Inc. (NUVB) |
About this indication
Oligodendroglioma context
Oncology·MeSH: Oligodendroglioma (D009837)
Also known as: Oligodendrogliomas
Frequently asked questions
How many drugs are in development for Oligodendroglioma?
BioSniper tracks 1 drug in development for Oligodendroglioma across 1 company.
How many clinical trials target Oligodendroglioma?
There are 8 clinical trials targeting Oligodendroglioma tracked by BioSniper.